Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 18/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24364976 | 1.00 | HDAC6 (0.41) | HDAC6TRPV1HSD17B10 | |
| SCHEMBL29081633 | 1.00 | HDAC6 (0.41) | HDAC6TRPV1HSD17B10 | |
| SCHEMBL29981506 | 0.88 | LOXL2 (0.46) | TRPV1 | |
| SCHEMBL30471172 | 0.87 | HDAC6 (0.32) | HDAC6 | |
| SCHEMBL32689101 | 0.87 | HDAC6 (0.32) | HDAC6 | |
| SCHEMBL24367600 | 0.87 | HDAC6 (0.32) | HDAC6 | |
| SCHEMBL24366026 | 0.87 | HDAC6 (0.32) | HDAC6 | |
| SCHEMBL24233968 | 0.86 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL25321028 | 0.85 | HDAC6 (0.32) | HDAC6 | |
| SCHEMBL24366820 | 0.85 | HDAC6 (0.35) | HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | HDAC6 815/4885TRPV1 1310/4885HSD17B10 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.